ArticleFrontiers in oncology2026

First-line CDK4/6 inhibitor treatment of HR-positive, HER2-negative metastatic breast cancer: real-world data from Ho Chi Minh City Oncology Hospital, Vietnam.

Thi Hong Duc Phan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.